CK19, Ki67, and β-catenin are highly expressed in HCC and can serve as molecular markers for post-operative recurrence and poor survival in HCC patients, providing a basis for precise prognostic evaluation in HCC. This evidence concerns the gene KRT19 and hepatocellular carcinoma.